Penumbra, Inc. Common Stock

Financials

Total de ativos 822.98 M1.24 B1.37 B1.56 B1.53 B1.83 B Total de passivos 185.19 M290.32 M372.03 M377.36 M382.25 M398.92 M Capital total 637.79 M953.93 M998.86 M1.18 B1.15 B1.43 B Total de passivos e patrimônio líquido 822.98 M1.24 B1.37 B1.56 B1.53 B1.83 B Dívida total —————— Dívida líquida ——————

Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm. In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by yearend.

PEN

Financials

Penumbra, Inc. Common Stock

Notícias

Baron Health Care Fund Q1 2026 Portfolio Activity

Ação da Penumbra atinge máxima de 52 semanas em US$ 328,69

Diamond Hill Long-Short Strategy Q1 2026 Portfolio Movers: Gains, Drags, And Trades

Acionistas da Penumbra aprovam fusão com a Boston Scientific

Penumbra (PEN) Misses Q1 Earnings Estimates

ALC vs. PEN: Which Stock Should Value Investors Buy Now?

Resultados da Penumbra em foco enquanto acordo com a Boston Scientific se aproxima

NovoCure Stock Shows Strength With RS Upgrade; Investors Should Watch For Next Entry

3 Reasons Why Penumbra (PEN) Is a Great Growth Stock

Riverwater Small Cap Strategy: Q1 2026 Buys, Sells, And Standouts

Meitav Investment House lança oferta pública para ações da Peninsula

Here's Why Penumbra (PEN) is a Strong Growth Stock